Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 43.80
Ask: 44.50
Change: -0.85 (-1.89%)
Spread: 0.70 (1.598%)
Open: 44.00
High: 44.00
Low: 44.00
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful defence of patent infringement in Asia

27 Nov 2018 07:00

RNS Number : 5471I
Benchmark Holdings PLC
27 November 2018
 

 

27 November 2018

 

 

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

 

Successful defence of patent infringement in Asia

 

Benchmark Holdings, the aquaculture genetics, health and nutrition business, announces that it has successfully prosecuted infringement of its patents by Marine-Tech International ("MTI") in Thailand (Thai Patent No. 38834 and Thai Patent No. 47896). The IP&IT court in Bangkok, Thailand has ruled that MTI infringed both patents, has ordered MTI to cease using Benchmark's patented technology and has awarded damages in Benchmark's favour, which may yet be subject to appeal.

 

These patents relate to the Company's market leading Artemia hatching and enrichment technologies, an important element of its advanced nutrition solutions. Following a period of dialogue with MTI, during which the Company requested MTI to cease and desist from using its patented technology, the Group filed a complaint at the IP&IT court in Bangkok in 2017. The summary judgement in favour of Benchmark was announced on 22nd November 2018.

 

The Company actively protects intellectual property rights, and this success demonstrates the robustness of Benchmark's patents and its ability to defend them globally in key markets.

 

Benchmark has a strong patent portfolio across products and processes in all of its three main divisions, which is the result of its advanced innovation, research and development and associated investment over the years. The Company's portfolio with 37 families and 221 patents is well balanced, with a mixture of robust granted applications to protect current products and new patent applications to support the business in the future.

 

Commenting on the Court ruling, Malcolm Pye, CEO, said:

 

"We are pleased the IP&IT court in Bangkok has ruled in our favour, vindicating the intellectual property which underpins the value of our innovative solutions and future product pipeline. Robust intellectual property protection will continue to be a core strategic area of focus for the Group."

 

Athene Blakeman, Group Legal Counsel, said:

 

"Benchmark robustly protects its intellectual property assets across the world and proactively monitors the market and our competitors for infringement. This intellectual property has been developed through many years of investment in cutting edge R&D and, while Benchmark strongly supports open and fair competition, we will take all necessary action, including initiating legal procedures as in this case, where we identify unfair infringement of our intellectual property."

 

 

For further information, please contact:

 

Benchmark Holdings plc

Tel: 020 7260 1000

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

MHP

Katie Hunt / Reg Hoare /Alistair de Kare-Silver

Tel: 020 3128 8742 07551 170 451

benchmark@mhpc.com

 

Notes to Editors:

 

Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services to serve its customers, helping them improve yield and efficiency in a sustainable way.

 

The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries and as at 31 March 2018 employed 1,028 people.

 

For further information on Benchmark please visit www.benchmarkplc.com@WeAreBenchmark

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGMMZMRVDGRZM
Date   Source Headline
23rd Jul 202011:05 amRNSSale of vaccine manufacturing assets
1st Jul 20207:00 amRNSSale of FishVet
30th Jun 20207:00 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSSale of Improve International
8th Jun 20204:54 pmRNSDirector/PDMR Shareholding - Replacement
8th Jun 202010:43 amRNSDirector/PDMR Shareholding
5th Jun 20205:50 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSSecond Quarter and Interim Results
27th May 20208:30 amRNSEquity Development Results Webinar
19th May 20207:00 amRNSNotice of Q2 and Interim Results
6th May 202012:09 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights
21st Apr 20207:00 amRNSDirector and Divisional Management Changes
7th Apr 20207:00 amRNSAppointment of Chief Executive Officer
2nd Apr 20207:00 amRNSCovid-19 update
31st Mar 202011:12 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSBlock Listing Six Monthly Review
18th Mar 20207:00 amRNSBlock Admission Application
16th Mar 202012:00 pmRNSDirector Dealings
12th Mar 20201:15 pmRNSResult of AGM
9th Mar 20202:01 pmRNSHolding(s) in Company
9th Mar 20201:46 pmRNSDIRECTOR DEALINGS
28th Feb 20207:00 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSQ1 Results
25th Feb 20209:43 amRNSDIRECTOR SHARE OPTIONS
21st Feb 202010:49 amRNSDirector/PDMR Shareholding
20th Feb 20204:10 pmRNSHolding(s) in Company
20th Feb 20209:15 amRNSHolding(s) in Company
17th Feb 20204:28 pmRNSResult of General Meeting and Total Voting Rights
17th Feb 20207:00 amRNSResult of Open Offer
11th Feb 20207:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
31st Jan 20207:00 amRNSTotal Voting Rights
30th Jan 20202:46 pmRNSTimetable for Placing and Open Offer
30th Jan 20207:00 amRNSPlacing and Open Offer
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20199:06 amRNSSecond Price Monitoring Extn
20th Dec 20199:00 amRNSPrice Monitoring Extension
20th Dec 20197:00 amRNSQ4 Results
20th Dec 20197:00 amRNSFull Year Results
4th Dec 20197:00 amRNSDirectorate Change
29th Nov 20197:00 amRNSQ4 and FY Trading Update & Notice of Results
29th Nov 20197:00 amRNSTotal Voting Rights
11th Nov 20197:00 amRNSChief Financial Officer Appointment Update
8th Nov 20197:00 amRNSInvesting in a sustainable future for aquaculture
31st Oct 20197:00 amRNSTotal Voting Rights
28th Oct 20197:00 amRNSUpdate on dissolution of JV with AquaChile
25th Oct 20198:10 amRNSHolding(s) in Company
25th Oct 20197:00 amRNSHolding(s) in Company
11th Oct 201911:15 amRNSDIRECTOR DEALINGS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.